Color Codes for Ophthalmic Medications
AAO cap color coding and why it matters
The American Academy of Ophthalmology (AAO) promotes a voluntary cap color-coding system for topical ocular medications to reduce dispensing errors and simplify complex regimens. When patients are using multiple drops, for example glaucoma therapy plus dry eye and allergy management, consistent cap colors provide an extra safety cue when labels are hard to read or vision is reduced. The table on this page summarizes common color associations by drug class.
Clinical safety and high-risk mix-ups
Cap color is a helpful cue, but it is not a substitute for verifying the label. Safety-critical distinctions such as tan caps (anti-infectives) versus pink caps (steroids) should be reinforced in counseling to reduce the risk of using a steroid on infectious keratitis. Red caps identify mydriatics and cycloplegics, and patients should be told these drops will dilate the pupil, blur near vision, and increase light sensitivity.
Generics, packaging differences, and refill checks
Generic manufacturers and compounding pharmacies can deviate from standard AAO colors because of packaging or supply constraints. For example, some prostaglandin products may appear with clear or white caps rather than teal. If a refill looks different, instruct patients to confirm the drug name and strength on the label before use. In the clinic, confirm class and indication when switching between branded and generic versions to keep education and workflows consistent.